Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
Gene silencing with virally delivered shRNA represents a promising approach for treatment of inherited neurodegenerative disorders. In the present study we develop a subpial technique, which we show in adult animals successfully delivers adeno-associated virus (AAV) throughout the cervical, thoracic...
Saved in:
Published in | Nature medicine Vol. 26; no. 1; pp. 118 - 130 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.01.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1078-8956 1546-170X 1546-170X |
DOI | 10.1038/s41591-019-0674-1 |
Cover
Summary: | Gene silencing with virally delivered shRNA represents a promising approach for treatment of inherited neurodegenerative disorders. In the present study we develop a subpial technique, which we show in adult animals successfully delivers adeno-associated virus (AAV) throughout the cervical, thoracic and lumbar spinal cord, as well as brain motor centers. One-time injection at cervical and lumbar levels just before disease onset in mice expressing a familial amyotrophic lateral sclerosis (ALS)-causing mutant
SOD1
produces long-term suppression of motoneuron disease, including near-complete preservation of spinal α-motoneurons and muscle innervation. Treatment after disease onset potently blocks progression of disease and further α-motoneuron degeneration. A single subpial AAV9 injection in adult pigs or non-human primates using a newly designed device produces homogeneous delivery throughout the cervical spinal cord white and gray matter and brain motor centers. Thus, spinal subpial delivery in adult animals is highly effective for AAV-mediated gene delivery throughout the spinal cord and supraspinal motor centers.
Injection of AAV–shRNA below the pial surface of the spinal cord prevents onset or ameliorates progression in a mouse model of ALS, and achieves widespread delivery to the spinal cord and brain motor centers in adult pigs and non-human primates. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 M.B.-H. and T.T. performed the mouse in vivo part of the study. M.R.N. and P.C. performed immunofluorescence staining, and quantitative and qualitative immunofluorescence image analysis. O.P. performed electrophysiologic recordings. Y.K., S.J., N.G.-P., J.D.C., H. Skalnikova, H. Studenovska, V.P. and J.J. performed the large animal studies. A.M. produced and validated the AAV9 vectors. S.G., W.Z. and E.T.A. performed postmortem MRI analysis. S.P.D., T.D.G. and S.L.P. conducted mRNA-seq analysis. Z.T. and I.V. performed qualitative and quantitative axon analysis. M.M.-D. performed animal breeding and genotyping. B.K.K., D.W.C. and M.M. designed the study and prepared the manuscript. All authors contributed to the final editing and approval of the manuscript. S.M., D.D. and S.D.C. were the project managers. Author contributions |
ISSN: | 1078-8956 1546-170X 1546-170X |
DOI: | 10.1038/s41591-019-0674-1 |